Callan Family Office’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$538K Buy
1,355
+87
+7% +$24.8K 0.01% 793
2026
Q1
$220K Sell
1,268
-1,745
-58% -$358K 0.01% 1038
2025
Q4
$772K Buy
3,013
+1,809
+150% +$474K 0.02% 620
2025
Q3
$313K Sell
1,204
-16
-1% -$4.21K 0.01% 695
2025
Q2
$298K Buy
+1,220
New +$304K 0.01% 775
2025
Q1
– Sell
-842
Closed -$214K – 594
2024
Q4
$214K Buy
+842
New +$226K 0.01% 586

Other funds holding HUM

Callan Family Office's HUM Position: Q2 2026 in Review

Callan Family Office increased its Humana (HUM) stake by 6.9% in Q2 2026, buying an estimated $24.8K and bringing the position to 1,355 shares worth $538K. The position accounts for 0.01% of the portfolio, ranked #793.

Callan Family Office first reported a position in HUM in Q4 2024 and has held it in 6 quarters since. The position peaked at $772K in Q4 2025. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Callan Family Office held 1,355 shares of Humana worth $538K as of Q2 2026.
  • Callan Family Office bought 87 Humana shares in Q2 2026, an estimated $24.8K.
  • Humana made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #793 holding.
  • Callan Family Office first reported a position in Humana in Q4 2024 and has held it in 6 quarters since.
  • Callan Family Office's Humana position peaked at $772K in Q4 2025.
  • 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.